“Promising” Epilepsy Trial Results Published in June 1 Issue of the Journal of the American Veterinary Association
We first reported on the encouraging preliminary results of Dr. Stephanie McGrath’s epilepsy trial last year. Now, the complete results of this groundbreaking pilot study have been published in the Journal of the American Veterinary Association’s June 1 issue. If you’ve got a pet with epilepsy, you’re going to want to pay attention to this study!
Clinical Trial Backs Up Anecdotal Evidence
We’ve been hearing from customers for years that our Pure Organic CBD Oil helps reduce the severity, frequency, and duration of seizures in their epileptic pets. We get thank you notes, rave reviews, and even videos that show the beneficial effects of our product. Now, we’re starting to see the fruits of our research in the form of clinical trial results.
Pilot Study Shows Significant Reduction in Seizures with CBD Treatment
Twenty six dogs with intractable idiopathic epilepsy were initially enrolled in the pilot study. After exclusions, sixteen dogs completed the 12-week trial. In this double blind study, the dogs were randomly assigned to a CBD group or placebo group. The CBD group received ABSC’s CBD-infused oil twice daily for 12 weeks while continuing their existing antiepileptic treatments. The placebo group received oil without CBD, and also continued their existing medications. All other parameters were consistent for both groups. Dr. McGrath and her colleagues at CSU compared seizure activity, adverse effects, and plasma CBD concentrations over the course of the twelve weeks, and found that 89% of the dogs in the CBD group saw a reduction in seizure frequency. Researchers also found a strong correlation between plasma (blood) CBD concentration and seizure frequency. Further studies will evaluate whether higher doses of CBD decrease seizure activity even further.
These results are groundbreaking when it comes to veterinary CBD usage, and they are generating lots of buzz in the veterinary community and beyond. Check out Dr. McGrath–and a nice closeup of our product (old label)–on the news in Denver:
More CBD Trials to Come
Based on the exciting results from this pilot study, Dr. McGrath is currently working on a larger epilepsy study supported by the AKC Canine Health Foundation. Stay tuned for more promising results, and visit the AKC Canine Health Foundation site to learn how you can help with their research initiatives. In the meantime you can purchase the very same CBD product used in Dr. McGrath’s study for your pet here at petpainfree.com. Whether your pet suffers from epilepsy, arthritis, inflammation, anxiety, or another disorder, ABSC Pure Organic CBD Oil may be able to provide relief.
ABSC Organics Cares Enough to Do the Research
At ABSC Organics, we put our money where our mouth is. We partner with some of the world’s best veterinary researchers because we believe in our product and in the power of CBD. Want to learn more about past, current, and future clinical trials with ABSC Pure Organic CBD Oil? Check out our Clinical Trial page for more info!